Turn Therapeutics Inc.
TTRX
$4.85
-$0.39-7.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -58.55% | 0.00% | -27.07% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 2.46% | 0.00% | 6.09% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 26.13% | 0.00% | 359.75% | 0.00% |
| Change in Net Operating Assets | 0.00% | 367.97% | 0.00% | -201.32% | 0.00% |
| Cash from Operations | 0.00% | 1.09% | 0.00% | -45.47% | 0.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 37.89% | 0.00% | -6.22% | 0.00% |
| Cash from Investing | 0.00% | 37.89% | 0.00% | -6.22% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 272.19% | 0.00% | 175.62% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 272.19% | 0.00% | 175.62% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 18,788.71% | 0.00% | 95.81% | 0.00% |